![]() ![]() 2īy late 1953, the tobacco industry faced a crisis of cataclysmic proportions. 1 Before that time, there had been a widespread perception, both within science and among the public, that scientific endeavors constituted a set of activities that were in large measure insulated from “interests.” Institutions have struggled over recent decades to discern new policies and approaches to mitigate the increasingly powerful influence of industries as they affect scientific investigation and the public good. In this sense, the tobacco industry invented the modern problem of conflicts of interest at midcentury. But the steps the industry took as it fashioned a new relationship with the scientific enterprise have become a powerful and influential model for the exertion of commercial interests within science and medicine since that time.Īs a result, industrial influence on scientific research and outcome has been a powerful legacy of the tobacco story. This, of course, is not to argue that the approach and strategy undertaken by big tobacco are necessarily typical of conventional industry–science relationships. ANY SYSTEMATIC INVESTIGATION of the modern relationship of medicine and science to industry must consider what has become the epiphenomenal case of the tobacco industry as it confronted new medical knowledge about the risk of cigarette smoking in the mid-20th century. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |